Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31falsetrue2024-01-010No description of principal activity0truefalse 02161998 2024-01-01 2024-12-31 02161998 2023-01-01 2023-12-31 02161998 2024-12-31 02161998 2023-12-31 02161998 c:Director1 2024-01-01 2024-12-31 02161998 d:CurrentFinancialInstruments 2024-12-31 02161998 d:CurrentFinancialInstruments 2023-12-31 02161998 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 02161998 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 02161998 d:ShareCapital 2024-12-31 02161998 d:ShareCapital 2023-12-31 02161998 c:FRS102 2024-01-01 2024-12-31 02161998 c:Audited 2024-01-01 2024-12-31 02161998 c:FullAccounts 2024-01-01 2024-12-31 02161998 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 02161998 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 02161998 6 2024-01-01 2024-12-31 02161998 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 02161998









PAM HEALTH LIMITED









FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
PAM HEALTH LIMITED
REGISTERED NUMBER: 02161998

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 4 
-
200

  
-
200

Current assets
  

Cash at bank and in hand
  
4,561
10,553

  
4,561
10,553

Creditors: amounts falling due within one year
 5 
(4,461)
(10,653)

Net current assets/(liabilities)
  
 
 
100
 
 
(100)

Total assets less current liabilities
  
100
100

  

Net assets
  
100
100


Capital and reserves
  

Called up share capital 
  
100
100

  
100
100


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 September 2026.

A Bones
Director

The notes on pages 2 to 3 form part of these financial statements.

Page 1

 
PAM HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

PAM Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is 9 Lakeside Drive (Also Known As 820 Mandarin Court), Centre Park, Warrington, England, WA1 1GG

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Exemption from preparing consolidated financial statements

The Company is a parent company that is also a subsidiary included in the consolidated financial statements of a larger group by a parent undertaking established under the law of any part of the United Kingdom and is therefore exempt from the requirement to prepare consolidated financial statements under section 400 of the Companies Act 2006.

 
2.3

Going concern

These financial statements are prepared on the going concern basis. The company ceased to trade from 1 December 2021 following the transfer of its trade to fellow subsidiary undertaking, Sankey Health Limited. The directors consider that the company has the ability to meet its financial obligations for a period of at least 12 months.

 
2.4

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 0 (2023 - 0).

Page 2

 
PAM HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Fixed asset investments





Investments in subsidiary companies

£





At 1 January 2024
200


Disposals
(200)



At 31 December 2024
-





5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Amounts owed to group undertakings
4,461
10,653

4,461
10,653



6.


Controlling party

People Asset Management Group Limited is the immediate parent company. PAM Healthcare Limited is the ultimate parent company and the largest and smallest group in which PAM Health Limited is a member and for which consolidated financial statements are prepared and publicly available. A copy of the group financial statements can be obtained from PAM Healthcare Limited, 9 Lakeside Drive (also known as 820 Mandarin Court), Centre Park, Warrington, England, WA1 1GG


7.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 26 September 2026 by Chris Speakman FCCA (Senior statutory auditor) on behalf of WR Partners.

Page 3